New treatment options for patients with advanced neuroendocrine tumors.
about
The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumorsMetastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM geneSomatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and TherapeuticsEverolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial.Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.Late anastomotic perforation following surgery for gastric neuroendocrine tumor complicated by perforated duodenal ulcer: a case report.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learnedCauses of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesFree somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization.Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Therapy innovation for the treatment of pancreatic neuroendocrine tumors.Profiling of ileal carcinoids.Advancements in pancreatic neuroendocrine tumors.Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas.Pancreatic neuroendocrine tumors
P2860
Q26740374-38F83885-7AA3-400C-BADC-942731D3F797Q34224906-3047FD75-76EB-4A08-A0F3-862DE650AA40Q35057473-A76F994C-B007-4E8B-B510-542D6869C97FQ36251342-8926FC9E-24C4-432B-BF19-44BECE3F4105Q36512778-EB5591DD-487F-4E93-9DBE-086DDC0730D4Q36700474-98876229-ADF8-4B7F-B55C-87E94FF5145FQ36849357-690F4BAD-B853-4F3A-998A-CA9B03D1E29DQ36871673-8F36C993-65BF-40D6-A380-CA505F0D21F7Q37056120-FB8062BD-0AB9-4196-B117-48118B80FAD8Q37125550-2EF52016-A1A3-44E9-8415-E295A9384BB1Q37365221-66D17273-6A10-4C91-B60F-162299304174Q37634917-3CC9DAA1-F22D-4A51-96C4-8A132CA95875Q37985518-0C3001AB-ED7D-49B8-B53A-1430B7304449Q37988905-011895D4-07DB-4891-9E4A-D23954D615BEQ38044219-A83285E2-031D-427B-98DE-C7E212C03747Q38125257-FB3091F4-100D-48E7-9B8C-E68F5C3C360DQ55360978-928458AC-848B-4EAE-B698-1A4F4131AE92Q56917284-8107D306-445D-4F3D-B723-B2D286BA4A70
P2860
New treatment options for patients with advanced neuroendocrine tumors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
New treatment options for patients with advanced neuroendocrine tumors.
@ast
New treatment options for patients with advanced neuroendocrine tumors.
@en
New treatment options for patients with advanced neuroendocrine tumors.
@nl
type
label
New treatment options for patients with advanced neuroendocrine tumors.
@ast
New treatment options for patients with advanced neuroendocrine tumors.
@en
New treatment options for patients with advanced neuroendocrine tumors.
@nl
prefLabel
New treatment options for patients with advanced neuroendocrine tumors.
@ast
New treatment options for patients with advanced neuroendocrine tumors.
@en
New treatment options for patients with advanced neuroendocrine tumors.
@nl
P2860
P1476
New treatment options for patients with advanced neuroendocrine tumors.
@en
P2093
Jennifer A Chan
Matthew H Kulke
P2860
P2888
P304
P356
10.1007/S11864-011-0148-2
P577
2011-06-01T00:00:00Z
P6179
1012261053